1324 related articles for article (PubMed ID: 30521880)
1. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
[TBL] [Abstract][Full Text] [Related]
2. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
Lyvers M; Meester M
J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
[TBL] [Abstract][Full Text] [Related]
3. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
[TBL] [Abstract][Full Text] [Related]
4. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
Barrett FS; Griffiths RR
Curr Top Behav Neurosci; 2018; 36():393-430. PubMed ID: 28401522
[TBL] [Abstract][Full Text] [Related]
5. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
Johnson MW
Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
[TBL] [Abstract][Full Text] [Related]
6. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
Stenbæk DS; Madsen MK; Ozenne B; Kristiansen S; Burmester D; Erritzoe D; Knudsen GM; Fisher PM
J Psychopharmacol; 2021 Apr; 35(4):459-468. PubMed ID: 33501857
[TBL] [Abstract][Full Text] [Related]
7. The use of classic psychedelics among adults: a Danish online survey study.
Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A
Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202
[TBL] [Abstract][Full Text] [Related]
8. Psilocybin occasioned mystical-type experiences.
James E; Robertshaw TL; Hoskins M; Sessa B
Hum Psychopharmacol; 2020 Sep; 35(5):e2742. PubMed ID: 32573835
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Applications of Classic Hallucinogens.
Bogenschutz MP; Ross S
Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684
[TBL] [Abstract][Full Text] [Related]
10. Human behavioral pharmacology of psychedelics.
Strickland JC; Johnson MW
Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564
[TBL] [Abstract][Full Text] [Related]
11. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
Kangaslampi S; Hausen A; Rauteenmaa T
J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
[TBL] [Abstract][Full Text] [Related]
12. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
Hendricks PS
Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
[TBL] [Abstract][Full Text] [Related]
13. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
Calleja-Conde J; Morales-García JA; Echeverry-Alzate V; Bühler KM; Giné E; López-Moreno JA
Addict Biol; 2022 Nov; 27(6):e13229. PubMed ID: 36301215
[TBL] [Abstract][Full Text] [Related]
14. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
Sweat NW; Bates LW; Hendricks PS
J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
[TBL] [Abstract][Full Text] [Related]
15. The psychedelic effects of cannabis: A review of the literature.
Wolinsky D; Barrett FS; Vandrey R
J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
[TBL] [Abstract][Full Text] [Related]
16. Psilocybin and Other Classic Psychedelics in Depression.
Nutt DJ; Peill JM; Weiss B; Godfrey K; Carhart-Harris RL; Erritzoe D
Curr Top Behav Neurosci; 2023 Nov; ():. PubMed ID: 37955822
[TBL] [Abstract][Full Text] [Related]
17. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
[TBL] [Abstract][Full Text] [Related]
19. Psychedelic Drugs in Biomedicine.
Kyzar EJ; Nichols CD; Gainetdinov RR; Nichols DE; Kalueff AV
Trends Pharmacol Sci; 2017 Nov; 38(11):992-1005. PubMed ID: 28947075
[TBL] [Abstract][Full Text] [Related]
20. Default Mode Network Modulation by Psychedelics: A Systematic Review.
Gattuso JJ; Perkins D; Ruffell S; Lawrence AJ; Hoyer D; Jacobson LH; Timmermann C; Castle D; Rossell SL; Downey LA; Pagni BA; Galvão-Coelho NL; Nutt D; Sarris J
Int J Neuropsychopharmacol; 2023 Mar; 26(3):155-188. PubMed ID: 36272145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
